查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1641694

2025 年全球心臟瓣膜市场报告

Cardiac Valve Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年心臟瓣膜市场规模将快速成长。到 2029 年，这一数字将成长至 212.6 亿美元，复合年增长率为 14.2%。预测期内的增长归因于对生物工程和组织工程心臟瓣膜的需求不断增加、全球人口老化、对心臟瓣膜疾病的治疗需求、心臟瓣膜疾病患者的远端医疗和远端患者监护、手术技术的改进和心臟瓣膜疾病的机器人辅助治疗，以及采用 3D 列印製造个人化心臟瓣膜。预测期内的关键趋势包括瓣膜置换和修復技术的进步、人工智慧（AI）在瓣膜疾病检测和治疗计划中的整合、采用3D列印製造个人化心臟瓣膜、瓣膜置换和修復技术的进步、手术技术的增强以及机器人辅助瓣膜手术。

心血管疾病发生率的不断上升将推动心臟瓣膜市场的成长。吸烟、肥胖、缺乏运动和其他心血管压力因素导致心血管疾病逐渐增加。冠状动脉疾病是一种常见病因，其特征是动脉中脂肪斑块的堆积。心臟相关疾病的激增导致对解决心臟瓣膜问题的心臟瓣膜的需求增加。截至2023年9月，根据世界卫生组织（WHO）的资料，心血管疾病占全球非传染性疾病（NCD）或慢性病相关死亡的很大一部分，约为74%。

预计医疗保健支出的增加将推动心臟瓣膜市场的扩张。医疗保健支出包括与医疗保健商品和服务相关的成本，是支持心臟瓣膜开发和可近性的关键因素。 2022年11月，加拿大卫生资讯研究所报告称，2022年医疗保健支出将成长0.8%，而2021年为7.6%，达到3,310亿美元。医疗成本上涨的趋势正在推动心臟瓣膜市场的成长。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情景，包括利率、通膨、地缘政治、新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球心臟瓣膜 PESTEL 分析（政治、社会、技术、环境、法律、驱动因素、阻碍因素）
  • 最终用途产业分析
  • 全球心臟瓣膜市场成长率分析
  • 全球心臟瓣膜市场表现：规模与成长，2019 年至 2024 年
  • 全球心臟瓣膜市场预测：2024-2029 年、2034 年规模与成长
  • 全球心臟瓣膜总目标市场 (TAM)

第六章 市场细分

  • 全球心臟瓣膜市场类型、表现及预测，2019-2024、2024-2029、2034
  • 组织心臟瓣膜
  • 经导管心臟瓣膜
  • 人工心臟瓣膜
  • 其他的
  • 全球心臟瓣膜市场各地区、绩效及预测，2019-2024、2024-2029、2034
  • 主动脉瓣
  • 二尖瓣
  • 其他的
  • 全球心臟瓣膜市场（按治疗、表现和预测）2019-2024、2024-2029、2034
  • 心臟瓣膜修復
  • 心臟瓣膜置换术
  • 全球心臟瓣膜市场（依最终使用者、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 医院和诊所
  • 专业中心
  • 心臟研究
  • 其他的
  • 全球心臟瓣膜市场、组织心臟瓣膜细分市场、类型、绩效及预测，2019-2024、2024-2029、2034
  • 生物瓣膜（猪、牛等）
  • 同种异体瓣膜
  • 全球心臟瓣膜市场、经导管心臟瓣膜细分市场、类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 经导管主动脉瓣置入术(TAVI) 瓣膜
  • 经导管二尖瓣瓣膜修復瓣膜
  • 全球心臟瓣膜市场、机械心臟瓣膜细分市场、类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 斜盘阀
  • 双叶瓣膜
  • 笼式球阀
  • 全球心臟瓣膜市场及其他细分市场，依类型、绩效及预测，2019-2024、2024-2029、2034
  • 导管
  • 附支架和无支架瓣膜

第七章 区域和国家分析

  • 全球心臟瓣膜市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球心臟瓣膜市场：依国家、表现及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第 17 章 德国市场

第 18 章 法国市场

第 19 章：义大利市场

第 20 章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第 25 章：加拿大市场

第26章 南美洲市场

第 27 章：巴西市场

第28章 中东市场

第 29 章：非洲市场

第 30 章竞争格局与公司概况

  • 心臟瓣膜市场：竞争格局
  • 心臟瓣膜市场：公司简介
    • Abbott Laboratories
    • Colibri Heart Valve LLC
    • TTK HealthCare Limited
    • Artivion Inc.
    • Edwards Lifesciences Corporation

第31章 其他大型创新企业

  • Boston Scientific Corporation
  • Jenavalve Technology Inc.
  • CryoLife Inc.
  • Lepu Medical Technology Co. Ltd.
  • Braile Biomedical
  • Sorin Group
  • Micro Interventional Devices Inc.
  • Medtronic Inc.
  • Lepu Medical Technology
  • Edward Lifesciences Corporation
  • Xeltis AG
  • Meril Life Sciences Pvt. Ltd.
  • Auto Tissue Berlin GmbH
  • On-X Life Technologies Inc.
  • Thubrikar Aortic Valve Inc.

第 32 章 全球竞争基准化分析与仪錶板

第33章 重大併购

第 34 章 近期市场趋势

第 35 章：市场潜力大的国家与策略

  • 2029 年心臟瓣膜市场 - 提供最多新机会的国家
  • 心臟瓣膜市场 2029- 提供最新兴机会的细分市场
  • 心臟瓣膜市场 2029-成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第 36 章 附录

简介目录
Product Code: r21193

Cardiac valves are artificial devices designed to regulate the flow of blood within the heart, ensuring unidirectional blood movement from the heart to other parts of the body. These implantable devices play a crucial role in replacing damaged valves that may have ceased functioning due to various diseases. The primary objective of cardiac valves is to maintain the proper flow of blood through the heart and into the major blood vessels connected to it.

The primary types of cardiac valves include tissue valves, transcatheter valves, mechanical valves, and other variations. Tissue heart valves, utilized in open-heart or minimally invasive surgeries, aim to prevent blood clot formation inside the vessels. These valves are crafted from durable and flexible animal tissue obtained from donors and are employed in cardiac valve repair and replacement procedures. Various positions in the heart, such as the aortic valve and mitral valve, necessitate the repair or replacement of cardiac valves. End-users of cardiac valves include hospitals, clinics, specialty centers, cardiac research institutes, and other healthcare facilities.

The cardiac valve market research report is one of a series of new reports from The Business Research Company that provides cardiac valve market statistics, including cardiac valve industry global market size, regional shares, competitors with a cardiac valve market share, detailed cardiac valve market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac valve industry. This cardiac valve market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cardiac valve market size has grown rapidly in recent years. It will grow from $10.89 billion in 2024 to $12.48 billion in 2025 at a compound annual growth rate (CAGR) of 14.6%. The growth in the historic period can be attributed to aging population and the associated increase in valvular heart disease, growth in the prevalence of risk factors like obesity and hypertension, improved diagnostic and imaging technologies for valve diseases, awareness campaigns and education on heart health and valve disease, and development of minimally invasive and transcatheter valve procedures.

The cardiac valve market size is expected to see rapid growth in the next few years. It will grow to $21.26 billion in 2029 at a compound annual growth rate (CAGR) of 14.2%. The growth in the forecast period can be attributed to increasing demand for bioengineered and tissue-engineered heart valves, aging global population andThe need for valve disease treatment, telemedicine and remote patient monitoring for valve patients, enhanced surgical techniques and robotics-assisted valve procedures, and adoption of 3D printing for personalized heart valve manufacturing. Major trends in the forecast period include advancements in valve replacement and repair techniques, integration of artificial intelligence (ai) for valve disease detection and treatment planning, adoption of 3D printing for personalized heart valve manufacturing, advancements in valve replacement and repair techniques, and enhanced surgical techniques and robotics-assisted valve procedures.

The increasing prevalence of cardiovascular diseases is poised to drive the growth of the cardiac valve market. Factors such as smoking, obesity, lack of physical activity, and other cardiovascular stressors contribute to a gradual rise in cardiovascular diseases. Coronary artery disease, characterized by the build-up of fatty plaques in arteries, is a common cause. This surge in heart-related ailments has heightened the demand for cardiac valves to address heart valve issues. As of September 2023, data from the World Health Organization indicates that cardiovascular diseases account for a substantial portion, approximately 74%, of global deaths related to non-communicable diseases (NCDs) or chronic conditions.

The expansion of the cardiac valves market is expected to be fueled by the increasing healthcare expenditure. Healthcare expenditure, encompassing costs associated with healthcare goods and services, is a critical factor supporting the development and accessibility of cardiac valves. In November 2022, the Canadian Institute for Health Information reported a rise in healthcare expenditure to 0.8%, amounting to $331 billion in 2022, compared to 7.6% in 2021. This upward trend in healthcare spending is a significant driver of the growth observed in the cardiac valves market.

A notable trend in the cardiac valve market is the integration of technological advancements. Major players in the industry are focusing on innovative technologies such as neochordae implantation, annuloplasty ring, and robotic surgery to enhance their market presence. These technological advancements contribute to less invasive treatment options for heart diseases, offering patients protection against life-threatening conditions such as heart stroke and cardiac arrest. In September 2022, Edwards, a leading US-based medical technology company, introduced the Sapien 3 Ultra Resilia transcatheter heart valve featuring anti-calcification technology. This technology platform was designed to irreversibly block calcium binding sites in bioprosthetic valves.

Major companies within the cardiac valves market are actively engaged in the development of innovative products, exemplified by the introduction of next-generation transcatheter aortic valve implantation (TAVI) systems to drive market revenues. Abbott, a prominent US-based medical device company, launched the Navitor TAVI system in December 2022. This self-expanding valve is designed to treat patients with symptomatic severe native aortic stenosis deemed at high or extreme risk for open-heart surgery. The Navitor TAVI system incorporates intelligent design features, including the smart PVL-sealing NaviSeal Cuff, stable and accurate placement, exceptional single-digit gradients, and uncompromised small vessel access, catering to a broad spectrum of routine to challenging anatomies.

In January 2022, Venus Medtech, a China-based company specializing in structural heart disease treatment, completed the acquisition of Cardiovalve Ltd., an Israel-based medical device company focused on developing a transfemoral mitral valve replacement system. This strategic move enables Venus Medtech to advance clinical research in Europe and the United States while accelerating clinical development and commercialization in China. The acquisition positions Venus Medtech as China's most comprehensive platform for treating mitral and tricuspid regurgitation.

Major companies operating in the cardiac valve market include Abbott Laboratories, Colibri Heart Valve LLC, TTK HealthCare Limited, Artivion Inc., Edwards Lifesciences Corporation, Boston Scientific Corporation, Jenavalve Technology Inc., CryoLife Inc., Lepu Medical Technology Co. Ltd., Braile Biomedical, Sorin Group, Micro Interventional Devices Inc., Medtronic Inc., Lepu Medical Technology, Edward Lifesciences Corporation, Xeltis AG, Meril Life Sciences Pvt. Ltd., Auto Tissue Berlin GmbH, On-X Life Technologies Inc., Thubrikar Aortic Valve Inc., LifeNet Health Inc.

North America was the largest region in the cardiac valve market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac valve market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the cardiac valve market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.

The cardiac valve market consists of sales of tricuspid valves and pulmonary valves. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cardiac Valve Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cardiac valve market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cardiac valve ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cardiac valve market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Tissue Heart Valves; Transcatheter Heart Valves; Mechanical Heart Valves; Other Types
  • 2) By Position: Aortic Valve; Mitral Valve; Other Positions
  • 3) By Treatment: Cardiac Valve Repair; Cardiac Valve Replacement
  • 4) By End-Users: Hospital And Clinics; Specialty Centers; Cardiac Research Institute; Other End Users
  • Subsegments:
  • 1) By Tissue Heart Valves: Bioprosthetic Valves (e.g., porcine, bovine); Homograft Valves
  • 2) By Transcatheter Heart Valves: Transcatheter Aortic Valve Implantation (TAVI) Valves; Transcatheter Mitral Valve Repair Valves
  • 3) By Mechanical Heart Valves: Tilting Disc Valves; Bileaflet Valves; Caged Ball Valves
  • 4) By Other Types: Conduits; Stented vs. Stentless Valves
  • Companies Mentioned: Abbott Laboratories; Colibri Heart Valve LLC; TTK HealthCare Limited; Artivion Inc.; Edwards Lifesciences Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cardiac Valve Market Characteristics

3. Cardiac Valve Market Trends And Strategies

4. Cardiac Valve Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Cardiac Valve Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Cardiac Valve PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Cardiac Valve Market Growth Rate Analysis
  • 5.4. Global Cardiac Valve Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Cardiac Valve Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Cardiac Valve Total Addressable Market (TAM)

6. Cardiac Valve Market Segmentation

  • 6.1. Global Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Tissue Heart Valves
  • Transcatheter Heart Valves
  • Mechanical Heart Valves
  • Other Types
  • 6.2. Global Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Aortic Valve
  • Mitral Valve
  • Other Positions
  • 6.3. Global Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cardiac Valve Repair
  • Cardiac Valve Replacement
  • 6.4. Global Cardiac Valve Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital And Clinics
  • Specialty Centers
  • Cardiac Research Institute
  • Other End Users
  • 6.5. Global Cardiac Valve Market, Sub-Segmentation Of Tissue Heart Valves, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bioprosthetic Valves (e.g., porcine, bovine)
  • Homograft Valves
  • 6.6. Global Cardiac Valve Market, Sub-Segmentation Of Transcatheter Heart Valves, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Transcatheter Aortic Valve Implantation (TAVI) Valves
  • Transcatheter Mitral Valve Repair Valves
  • 6.7. Global Cardiac Valve Market, Sub-Segmentation Of Mechanical Heart Valves, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Tilting Disc Valves
  • Bileaflet Valves
  • Caged Ball Valves
  • 6.8. Global Cardiac Valve Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Conduits
  • Stented vs. Stentless Valves

7. Cardiac Valve Market Regional And Country Analysis

  • 7.1. Global Cardiac Valve Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Cardiac Valve Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cardiac Valve Market

  • 8.1. Asia-Pacific Cardiac Valve Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cardiac Valve Market

  • 9.1. China Cardiac Valve Market Overview
  • 9.2. China Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cardiac Valve Market

  • 10.1. India Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cardiac Valve Market

  • 11.1. Japan Cardiac Valve Market Overview
  • 11.2. Japan Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cardiac Valve Market

  • 12.1. Australia Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cardiac Valve Market

  • 13.1. Indonesia Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cardiac Valve Market

  • 14.1. South Korea Cardiac Valve Market Overview
  • 14.2. South Korea Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cardiac Valve Market

  • 15.1. Western Europe Cardiac Valve Market Overview
  • 15.2. Western Europe Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cardiac Valve Market

  • 16.1. UK Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cardiac Valve Market

  • 17.1. Germany Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cardiac Valve Market

  • 18.1. France Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cardiac Valve Market

  • 19.1. Italy Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cardiac Valve Market

  • 20.1. Spain Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cardiac Valve Market

  • 21.1. Eastern Europe Cardiac Valve Market Overview
  • 21.2. Eastern Europe Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cardiac Valve Market

  • 22.1. Russia Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cardiac Valve Market

  • 23.1. North America Cardiac Valve Market Overview
  • 23.2. North America Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cardiac Valve Market

  • 24.1. USA Cardiac Valve Market Overview
  • 24.2. USA Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cardiac Valve Market

  • 25.1. Canada Cardiac Valve Market Overview
  • 25.2. Canada Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cardiac Valve Market

  • 26.1. South America Cardiac Valve Market Overview
  • 26.2. South America Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cardiac Valve Market

  • 27.1. Brazil Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cardiac Valve Market

  • 28.1. Middle East Cardiac Valve Market Overview
  • 28.2. Middle East Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cardiac Valve Market

  • 29.1. Africa Cardiac Valve Market Overview
  • 29.2. Africa Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cardiac Valve Market Competitive Landscape And Company Profiles

  • 30.1. Cardiac Valve Market Competitive Landscape
  • 30.2. Cardiac Valve Market Company Profiles
    • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Colibri Heart Valve LLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. TTK HealthCare Limited Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Artivion Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Edwards Lifesciences Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Cardiac Valve Market Other Major And Innovative Companies

  • 31.1. Boston Scientific Corporation
  • 31.2. Jenavalve Technology Inc.
  • 31.3. CryoLife Inc.
  • 31.4. Lepu Medical Technology Co. Ltd.
  • 31.5. Braile Biomedical
  • 31.6. Sorin Group
  • 31.7. Micro Interventional Devices Inc.
  • 31.8. Medtronic Inc.
  • 31.9. Lepu Medical Technology
  • 31.10. Edward Lifesciences Corporation
  • 31.11. Xeltis AG
  • 31.12. Meril Life Sciences Pvt. Ltd.
  • 31.13. Auto Tissue Berlin GmbH
  • 31.14. On-X Life Technologies Inc.
  • 31.15. Thubrikar Aortic Valve Inc.

32. Global Cardiac Valve Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cardiac Valve Market

34. Recent Developments In The Cardiac Valve Market

35. Cardiac Valve Market High Potential Countries, Segments and Strategies

  • 35.1 Cardiac Valve Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Cardiac Valve Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Cardiac Valve Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer